LivaNova PLC
LIVN
Xếp hạng trong cổ phiếu
#3793
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
Giá cổ phiếu
$80.01
Vốn hóa thị trường
$4.40B
Thay đổi (1 ngày)
2.39%
Thay đổi (1 năm)
47.89%
Quốc gia
GB
Giao dịch LivaNova PLC (LIVN)
Danh mục
Healthcare
EPS của LivaNova PLC (LIVN)
EPS tính đến June 2026 TTM: $3.45
Theo các báo cáo tài chính mới nhất và giá cổ phiếu của LivaNova PLC, EPS hiện tại của công ty (TTM) là $3.45. Vào cuối năm 2023, công ty có EPS là $0.33, tăng so với EPS năm 2022 là $-1.61.
Lịch sử EPS của LivaNova PLC từ 2000 đến 2026
EPS vào cuối mỗi năm
| Năm | EPS | Thay đổi |
|---|---|---|
| 2026 (TTM) | $3.45 | 194.87% |
| 2024 | $1.17 | 254.55% |
| 2023 | $0.33 | -120.50% |
| 2022 | $-1.61 | -39.93% |
| 2021 | $-2.68 | -62.04% |
| 2020 | $-7.06 | 119.25% |
| 2019 | $-3.22 | -17.65% |
| 2018 | $-3.91 | 651.92% |
| 2017 | $-0.52 | -59.69% |
| 2016 | $-1.29 | -158.90% |
| 2015 | $2.19 | 8.42% |
| 2014 | $2.02 | 20.24% |
| 2013 | $1.68 | 29.23% |
| 2012 | $1.30 | -22.16% |
| 2011 | $1.67 | -40.99% |
| 2010 | $2.83 | 183.00% |
| 2009 | $1.00 | -356.41% |
| 2008 | $-0.39 | -80.60% |
| 2007 | $-2.01 | -15.19% |
| 2006 | $-2.37 | 364.71% |
| 2005 | $-0.51 | -275.86% |
| 2004 | $0.29 | 20.83% |
| 2003 | $0.24 | -119.83% |
| 2002 | $-1.21 | 611.76% |
| 2000 | $-0.17 | 0.00% |
EPS cho các công ty hoặc đối thủ cạnh tranh tương tự
| Công ty | EPS | Chênh lệch EPS | Quốc gia |
|---|---|---|---|
| $3.11 | -9.86% |
US
|
|
| $3.59 | 4.06% |
IE
|
|
| $9.73 | 182.03% |
US
|
|
| $2.48 | -28.12% |
US
|
|
| - | - |
DE
|
